/PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") a leader in advanced proprietary technology for.
Marker Therapeutics Reports Fiscal Year 2020 Operating and Financial Results
- Dosed first patient in the Company s Phase 2 trial of MT-401, its lead MultiTAA-specific T cell product candidate, for the treatment of post-transplant acute myeloid leukemia -
- Completed construction of new in-house cGMP manufacturing facility in Houston to supply MultiTAA-specific T cell products, including MT-401, for clinical activities and potential commercialization; facility expected to be fully operational in 1H 2021 -
News provided by
Share this article
Share this article
HOUSTON, March 9, 2021 /PRNewswire/ Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today provided a corporate update and reported financial results for the fiscal year ended December 31, 2020.
Share this article
Share this article
PITTSBURGH, March 9, 2021 /PRNewswire/ SoftWriters, the leading long-term care pharmacy management provider, today announced an integrated partnership with healthcare technology provider, Iron Bridge, designed to help long-term care pharmacies streamline and simplify the dynamic COVID-19 vaccination roll-out process with innovative technology solutions.
The recent partnership highlights the growth and solidarity of Pittsburgh s technology ecosystem; positioning the partners to advance the region s impact with their exciting and important joint-mission. SoftWriters, a pioneer in the long-term care pharmacy landscape has been operating and headquartered in Pittsburgh for over thirty years. Recently awarded a Top Pittsburgh workplace for the second year running - SoftWriters has become a force in both the long-term care and Pittsburgh Technology space.
Antigone Skoulas, DDS Champions Dentists Role in COVID Vaccination
As COVID vaccinations are deployed, dentists are playing a significant role in administering them. Dr. Antigone Skoulas, DDS explains.
News provided by
Share this article
Share this article
SAN FRANCISCO, March 9, 2021 /PRNewswire/ Across the country, COVID-19 vaccinations are slowly but surely being distributed, potentially signaling the endgame for the ongoing pandemic. Actually, getting the vaccines to people who need them has posed a number of logistical problems, including a deficit of trained healthcare providers to administer the shots. In a new statement to the press, San Francisco dentist Antigone Skoulas, DDS explains how she and her colleagues are offering their services.